文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

县级医院ICU呼吸机相关性肺炎的危险因素及病原学分析:三年病例分析

[Risk factors and etiological analysis of ventilator-associated pneumonia: three year's cases analysis of intensive care unit in county hospital].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2018-01-01
一句话结论县级医院ICU机械通气>48小时患者VAP发生率40.60%,脑损伤、脑血管意外、机械通气>7天、白蛋白<28 g/L和气管切开为独立危险因素,病原以G-菌为主且多重耐药,多重耐药菌感染患者死亡率更高。

该研究纳入2016年1月至2018年6月黄山市歙县人民医院ICU机械通气>48小时的234例患者,VAP发生95例,发生率40.60%。多因素Logistic回归显示脑损伤、脑血管意外、机械通气>7天、白蛋白<28 g/L和气管切开是VAP独立危险因素。95例VAP患者痰培养分离108株病原菌,G-菌占86.11%,肺炎克雷伯菌分离率最高(31.48%)。多重耐药菌感染患者死亡率51.85%(28/52)显著高于非多重耐药菌感染患者30.56%(11/36)(χ²=4.240,P=0.046)。

要点

  • VAP发生率为40.60%(95/234),脑损伤患者VAP风险OR=41.40(95%CI 2.14-799.60,P=0.014),脑血管意外OR=36.07(95%CI 1.86-699.64,P=0.018)。
  • 机械通气>7天(OR=1.23,95%CI 1.11-1.36,P<0.001)、白蛋白<28 g/L(OR=2.27,95%CI 1.03-5.01,P=0.042)、气管切开(OR=3.33,95%CI 1.30-8.56,P=0.012)为独立危险因素。
  • VAP病原以G-菌为主(86.11%),肺炎克雷伯菌分离率最高(31.48%),其次为铜绿假单胞菌(22.22%)、鲍曼不动杆菌(9.26%)、嗜麦芽窄食单胞菌(8.33%)。
  • 肺炎克雷伯菌对阿米卡星、美罗培南和多黏菌素100%敏感,原文建议作为首选药物;铜绿假单胞菌对阿米卡星、妥布霉素和多黏菌素100%敏感,对复方磺胺甲噁唑100%耐药。
  • 多重耐药菌感染患者死亡率51.85%(28/52)显著高于非多重耐药菌感染患者30.56%(11/36)(χ²=4.240,P=0.046)。

适用人群与场景

  • 纳入2016年1月至2018年6月黄山市歙县人民医院ICU机械通气>48小时的234例患者。

诊断标准与关键阈值

  • VAP诊断依据原文未给出具体标准;按是否发生VAP分为VAP组(95例)和非VAP组(139例)。

处置流程与药物剂量

  • 肺炎克雷伯菌对阿米卡星、美罗培南和多黏菌素100%敏感,原文建议作为首选药物。
  • 铜绿假单胞菌对阿米卡星、妥布霉素和多黏菌素100%敏感,对复方磺胺甲噁唑100%耐药。
  • 嗜麦芽窄食单胞菌对复方磺胺甲噁唑100%敏感,对阿米卡星、哌拉西林、哌拉西林他唑巴坦和妥布霉素100%耐药。
  • 鲍曼不动杆菌对头孢西丁、头孢呋辛和POT100%敏感(原文此处写作POT,未给出全称)。
  • 金黄色葡萄球菌对庆大霉素、呋喃妥因、利福平、万古霉素和替考拉宁100%敏感,对克林霉素和青霉素耐药率均80.00%。

红旗征与不能漏的情况

  • 脑损伤或脑血管意外患者VAP风险显著升高(OR分别为41.40和36.07),需警惕VAP发生。
  • 白蛋白<28 g/L、机械通气>7天、气管切开的患者VAP风险增加。
  • 多重耐药菌感染患者死亡率51.85%(28/52),显著高于非多重耐药菌感染患者30.56%(11/36)(P=0.046)。

研究设计与关键结果

  • 研究类型为单中心回顾性病例分析,纳入234例机械通气>48小时患者,VAP发生95例,发生率40.60%。
  • 单因素分析显示VAP组与非VAP组在既往病史、机械通气时间、ICU住院时间、白蛋白<28 g/L、抗生素暴露和气管切开方面差异有统计学意义,在性别、年龄、糖皮质激素、镇静剂、胃动力和昏迷方面无显著差异。
  • 多因素Logistic回归显示脑损伤(OR=41.40,95%CI 2.14-799.60,P=0.014)、脑血管意外(OR=36.07,95%CI 1.86-699.64,P=0.018)、机械通气>7天(OR=1.23,95%CI 1.11-1.36,P<0.001)、白蛋白<28 g/L(OR=2.27,95%CI 1.03-5.01,P=0.042)和气管切开(OR=3.33,95%CI 1.30-8.56,P=0.012)为VAP独立危险因素。
  • 95例VAP患者痰培养共分离108株病原菌,G-菌占86.11%(93/108),肺炎克雷伯菌31.48%(34/108)、铜绿假单胞菌22.22%(24/108)、鲍曼不动杆菌9.26%(10/108)、嗜麦芽窄食单胞菌8.33%(9/108);G+菌占6.48%(7/108),其中金黄色葡萄球菌4.63%(5/108);真菌占7.41%(8/108)。
  • 多重耐药菌感染患者死亡率51.85%(28/52)显著高于非多重耐药菌感染患者30.56%(11/36)(χ²=4.240,P=0.046)。

证据类型、等级与局限

  • 证据类型:单中心回顾性病例分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对脑损伤、脑血管意外、机械通气>7天、白蛋白<28 g/L或气管切开的ICU患者应警惕VAP发生。
  • VAP经验性治疗需覆盖G-菌尤其是肺炎克雷伯菌和铜绿假单胞菌,并考虑多重耐药可能;肺炎克雷伯菌对阿米卡星、美罗培南和多黏菌素100%敏感,原文建议作为首选药物。
  • 多重耐药菌感染与更高死亡率相关(51.85% vs 30.56%,P=0.046),需关注病原学结果和耐药监测。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the risk factors of ventilator-associated pneumonia (VAP) and the distribution and drug resistance of pathogens in intensive care unit (ICU) of county hospital.

METHODS: 234 patients on mechanical ventilation for more than 48 hours admitted to ICU of Shexian People's Hospital of Huangshan City from January 2016 to June 2018 were enrolled. The clinical data of all patients including gender, age, past medical history, exposure to antibiotics, medication, the duration of mechanical ventilation, the length of ICU stay, serum albumin, tracheotomy, re-intubation, prognosis, and pathogenic bacteria and drug sensitivity test of VAP patients were collected. The patients were divided into VAP group and non-VAP group according to the occurrence of VAP. The differences of each index between the two groups were compared. The risk factors of VAP were analyzed by multivariate Logistic regression. The distribution and drug resistance of pathogenic bacteria in sputum culture of lower respiratory tract of VAP patients were analyzed.

RESULTS: Among the 234 patients on mechanical ventilation, 95 patients had VAP, and the incidence of VAP was 40.60%. (1) Risk factors of VAP: it was shown by univariate analysis that there were significant differences between VAP patients and non-VAP patients in past history, the duration of mechanical ventilation, the length of ICU stay, albumin < 28 g/L, antibiotic exposure and tracheotomy, but there were no significant differences in gender, age, glucocorticoid, sedative, gastric motility and coma between the two groups. It was shown by multivariate Logistic regression analysis that brain injury and cerebrovascular accident, the duration of mechanical ventilation > 7 days, albumin < 28 g/L and tracheotomy were independent risk factors for VAP occurrence [brain injury: odds ratio (OR) = 41.40, 95% confidence interval (95%CI) = 2.14-799.60, P = 0.014; cerebrovascular accident: OR = 36.07, 95%CI = 1.86-699.64, P = 0.018; the duration of mechanical ventilation > 7 days: OR = 1.23, 95%CI = 1.11-1.36, P < 0.001; albumin < 28 g/L: OR = 2.27, 95%CI = 1.03-5.01, P = 0.042; tracheotomy: OR = 3.33, 95%CI = 1.30-8.56, P = 0.012]. (2) Distribution and drug resistance of VAP pathogens: a total of 108 strains of pathogens were isolated from sputum samples of 95 patients with VAP. Gram-negative (G-) bacteria accounted for 86.11% (93/108). The isolation rate of Klebsiella pneumoniae was the highest, reaching 31.48% (34/108); the isolation rates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Acinetobacter baumannii were 22.22% (24/108), 8.33% (9/108) and 9.26% (10/108), respectively. Gram-positive (G+) bacteria accounted for 6.48% (7/108), of which Staphylococcus aureus was 4.63% (5/108); and fungi was 7.41% (8/108). Drug resistance analysis showed that Klebsiella pneumoniae was 100% sensitive to amikacin (AMK), meropenem (MEM) and polymyxin (POL), and were suggested as the preferred drug. Pseudomonas aeruginosa was 100% sensitive to AMK, tobramycin (TOB) and POL, but 100% resistant to compound trimethoprim (PCST). Stenotrophomonas maltophilia was 100% sensitive to PCST and 100% resistant to AMK, piperacillin (PIP), piperacillin tazobactam (TZP) and TOB. Acinetobacter baumannii was 100% sensitive to cefoxitin (FOX), cefuroxime (CXM) and POT. Staphylococcus aureus was 100% sensitive to gentamicin (GEN), furantoin (NIT), rifampicin (RIF), vancomycin (VAN) and teicoplanin (TEC), while the drug resistance to clindamycin (CLI) and penicillin (PEN) was high (both 80.00%). Most pathogens were multidrug-resistant. The mortality of patients with multidrug resistant bacteria infection was significantly higher than that of non-multidrug resistant bacteria infection [51.85% (28/52) vs. 30.56% (11/36), χ 2 = 4.240, P = 0.046].

CONCLUSIONS: VAP was associated with brain injury and cerebrovascular accident, duration of mechanical ventilation < 7 days, albumin > 28 g/L and tracheotomy. VAP patients were infected mainly with G- bacteria and showed multiple drug resistance.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Hu Z, Zhou S. [Risk factors and etiological analysis of ventilator-associated pneumonia: three year's cases analysis of intensive care unit in county hospital]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 30439311. doi:10.3760/cma.j.issn.2095-4352.2018.010.005

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。